KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Co-Diagnostics (CODX) Equity Income (2020 - 2021)

Historic Equity Income for Co-Diagnostics (CODX) over the last 2 years, with Q4 2021 value amounting to -$29145.0.

  • Co-Diagnostics' Equity Income rose 8774.97% to -$29145.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$430433.0, marking a year-over-year decrease of 15529.82%. This contributed to the annual value of -$430433.0 for FY2021, which is 15529.82% down from last year.
  • As of Q4 2021, Co-Diagnostics' Equity Income stood at -$29145.0, which was up 8774.97% from -$64940.0 recorded in Q3 2021.
  • Co-Diagnostics' Equity Income's 5-year high stood at $748557.0 during Q3 2020, with a 5-year trough of -$464943.0 in Q1 2021.